Mira Pharmaceuticals, Inc.MIRA
Price (close)
$0.84
Market cap
$35.3M
P/E
—
Revenue (TTM)
—
Net income
-$9.5M
Dividend yield
—
1-year total return
-35.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Mira Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | — | -$7.1M | -$12.0M | -$7.9M | -$10.4M |
More on MIRA.
- Mira Pharmaceuticals, Inc. summary
- Mira Pharmaceuticals, Inc. financial statements
- Mira Pharmaceuticals, Inc. key metrics
- Mira Pharmaceuticals, Inc. health scores and style box
- Mira Pharmaceuticals, Inc. earnings
- Mira Pharmaceuticals, Inc. dividends
- Mira Pharmaceuticals, Inc. valuation
- Mira Pharmaceuticals, Inc. ownership and insiders
- Mira Pharmaceuticals, Inc. peers
Figures from Mira Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.